Immunotherapy for Management of Stage 3B NSCLC

Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua SabariПодробнее

stage 3 lung cancer Diagnosis and treatmentПодробнее

Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLCПодробнее

Lung Cancer New Treatment 2023Подробнее

[lung]The role of durvalumab in patients with stage 3 lung cancer in a real hospitalПодробнее

2023 Best of Lung: Targeted Therapies in Lung CancerПодробнее

How Breakthroughs in Immunotherapy are Helping Non-Small Cell Lung Cancer Patients Live LongerПодробнее

Lung Cancer StagingПодробнее

Lung Cancer Breakout: Breakthrough treatments for longer lifeПодробнее

Treatment of Unresectable Stage 3 Non-Small Cell Lung CancerПодробнее

Advances in the management of Thoracic Malignancies 3 Sep 2021 Day1 Part 2Подробнее

Immunotherapy for Non Small Cell Lung Cancer | types of immunotherapy for lung cancerПодробнее

Immunotherapy in stage III NSCLC + metastatic diseaseПодробнее

Metastatic lung cancer | Treatment of stage IV lung cancer | Immunotherapy | Targeted therapyПодробнее

Panel discussion | Dr Naresh Somani | Immunotherapy in stage 3 NSCLCПодробнее

Adjuvant therapy for Early Stage Lung Cancer – Case Based Discussion for Patient with Stage 1B NSCLCПодробнее

Maximizing the Potential of Immunotherapy in Unresectable Stage III NSCLCПодробнее

Adjuvant EGFR-Targeted Therapy as a Game Changer in Multimodal NSCLC ManagementПодробнее

Horizon - Role of Immunotherapy in the Management of Lung Cancer - 04 AugustПодробнее

Immunotherapies in Lung Cancer | 2022 Evolution ConferenceПодробнее